Life Science Cluster Flemingsberg
About
Life Science Cluster Flemingsberg is a project that works to strengthen collaboration between industry, academia, and healthcare and foster enhanced conditions for establishment, growth, and innovation within life science in Flemingsberg.
Through this initiative, we work to help stakeholders find the right infrastructure, expertise and connections, create meeting places and networks that connect the ecosystem, and promote sustainable collaboration and circular economy.
Life Science Cluster Flemingsberg is led by the Flemingsberg Science Foundation and co-financed by the European Regional Development Fund. The project is carried out in collaboration with co-financiers Region Stockholm, Botkyrka Municipality, Huddinge Municipality, and Hemsö, and in close partnership with Karolinska Institutet and Region Stockholm’s Life Science Office.
What can we do for you?
We’re here to help you establish, find lab space or specialized research infrastructure, connect with the right partners, or simply explore all the opportunities available in Flemingsberg. Get in touch with us and we’ll tell you more about how we can help you or your company navigate the ecosystem.
CONTACT OUR TEAM
Natasha Bank
Cluster Manager, Flemingsberg Science
natasha.bank@flemingsbergscience.se
+46 737 77 14 77
Angela Hoyer
Networks and Event Manager, Flemingsberg Science
angela.hoyer@flemingsbergscience.se
+46 767 71 63 03
Ellen Mäkipiha
Communications Officer, Flemingsberg Science
ellen.makipiha@flemingsbergscience.se
+46 761 17 76 37
EVENTS
NEWS
It’s official – Alfa Laval has opened its new premises in Flemingsberg!
The new 8,000 m² innovation center brings together 700 experts who push the boundaries of future solutions in energy, food, pharma and marine transport every day. An investment that truly shows how important Swedish industrial expertise, open collaborations and continued R&D are – not only for Alfa Laval, but for the whole of Europe.
50 years of life-changing therapies
On November 12 1975, the first allogeneic bone marrrow transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. On November 12 1975, the first allogeneic stem cell transplantation in Sweden was performed at Huddinge Hospital, here in Flemingsberg. From nuclear catastrophe the foundations of bone marrow transplantation had emerged, and with it, the birth of modern stem cell therapy — the same principles that today underpin cell and gene therapies and CAR-T treatments.
OptiCell Solutions enters a research collaboration with Karolinska Institutet
With the goal of supporting academia, healthcare, and industry in developing the cell and gene therapies of the future, OptiCell Solutions established its operations in Flemingsberg last year. The company has now entered into a research collaboration with Karolinska Institutet, marking a significant step in the desired direction.
The Park Novum inaugurated!
On November 5, the doors to The Park Novum opened – a new co-working space in Novum Research Park. The festivities came with a Halloween theme, and gathered over 150 participants who celebrated together.
Together for the medicine of the future – Karolinska ATMP Centre and ATMP Centre Uppsala strengthens collaboration in advanced therapies
A letter of intent has been signed between the Karolinska ATMP Center and the ATMP Center Uppsala to deepen collaboration in the field of advanced therapies (ATMP). The initiative was celebrated with a joint kick-off at the end of October, where hopes for new research breakthroughs and benefits for patients were in focus.
The Flemingsberg Science Foundation welcomes Angela Hoyer as the new Networks and Event Manager
With a background as a researcher at Karolinska Institutet and experience from academia, industry, and networking, Angela Hoyer, the new Networks and Event Manager at the Flemingsberg Science Foundation, is passionate about developing the life science sector. In her new role, Angela looks forward to creating meeting places where collaborations can grow, while also contributing to Flemingsberg’s continued development as a strong international hub for research and innovation.
